We are 2-sulfanylpyrimidine CAS:131242-36-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Yellow lamellar crystalline | Conform |
| Assay(HPLC) (Contains one isomer) |
≥98% | 98.7% |
| Melting point | ≥200℃ | 225-226℃ |
| Loss on drying | ≤1.0% | 0.80% |
| Heavy metal | ≤10ppm | Conform |
| Residue on ignition | ≤0.5% | 0.41% |
| Conclusion | Conforms to Factory Standard | |
Market News:Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France. ethyl 3-ethyl-7,11-dimethyldodeca-2,4-dienoate manufacturer.The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. Methyl-bis-(3-methyl-2-methylene-but-3-enyl)-amine supplier.A new post-hoc analysis of pooled data from the TULIP phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and arthritis across three different disease measures each, compared to placebo, in patients with moderate to severe systemic lupus erythematosus (SLE). bis(N-D-glucosyl-3-aminopropionato)nickel(II)*water producer.
| Product Name | |
|---|---|
| 1,8-Bis(trimethoxysily)octane Cas:105566-68-5 | View Details |
| CDDO-2-P-Im Cas:1883650-95-0 | View Details |
| 1-butyl-3-methylimidazolium dibutyl phosphate | View Details |